New aspects on patients affected by dysferlin deficient muscular dystrophy

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 9, 2010, Pages 946-953

  Klinge, Lars ^a,b   Aboumousa, Ahmed ^a   Eagle, Michelle ^a   Hudson, Judith ^a   Sarkozy, Anna ^a   Vita, Gianluca ^a   Charlton, Richard ^a   Roberts, Mark ^c   Straub, Volker ^a   Barresi, Rita ^a   Lochmüller, Hanns ^a   Bushby, Kate ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c Greater Manchester Neurosciences Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DYSFERLIN; CREATINE KINASE; DYSF PROTEIN, HUMAN; MEMBRANE PROTEIN; MUSCLE PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOCHEMISTRY; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; EXERCISE; FEMALE; FITNESS; GASTROCNEMIUS MUSCLE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; INDEL MUTATION; LIMB GIRDLE MUSCULAR DYSTROPHY; MALE; MIYOSHI MYOPATHY; MUSCLE BIOPSY; MUSCLE STIFFNESS; MUSCULAR DYSTROPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; UNITED KINGDOM; WESTERN BLOTTING; GENETICS; METABOLISM; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; ONSET AGE; PATHOLOGY; PHENOTYPE; SKELETAL MUSCLE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; CHILD; CREATINE KINASE; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUTATION; PHENOTYPE; PHYSICAL FITNESS;

EID: 77956624283     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.178038     Document Type: Article

References (31)

1. Bashir R, Britton S, Strachan T, et al. A gene related to caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2b. Nat Genet 1998;20:37-42. (Pubitemid 28410340)
2. Liu J, Aoki M, Illa I, et al. Dysferlin, a novel skeletal muscle gene, is mutated in miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998;20:31-6.
3. Illa I, Serrano-Munuera C, Gallardo E, et al. Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol 2001;49:130-4. (Pubitemid 32163018)
4. Nguyen K, Bassez G, Krahn M, et al. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. Arch Neurol 2007;64:1176-82. (Pubitemid 47258078)
5. Nguyen K, Bassez G, Bernard R, et al. Dysferlin mutations in LGMD2b, Miyoshi myopathy, and atypical dysferlinopathies. Hum Mutat 2005;26:165.
6. Ueyama H, Kumamoto T, Horinouchi H, et al. Clinical heterogeneity in dysferlinopathy. Intern Med 2002;41:532-6.
7. Krahn M, Beroud C, Labelle V, et al. Analysis of the DYSF mutational spectrum in a large cohort of patients. Hum Mutat 2008;30:E345-75.
8. Linssen WH, Notermans NC, Van Der Graaf Y, et al. Miyoshi-type distal muscular dystrophy. Clinical spectrum in 24 dutch patients. Brain 1997;120:1989-96.
9. Han R, Bansal D, Miyake K, et al. Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. J Clin Invest 2007;117:1805-13. (Pubitemid 47036314)
10. Wenzel K, Geier C, Qadri F, et al. Dysfunction of dysferlin-deficient hearts. J Mol Med 2007;85:1203-14.
11. Guglieri M, Magri F, D'angelo MG, et al. Clinical, molecular, and protein correlations in a large sample of genetically diagnosed italian limb girdle muscular dystrophy patients. Hum Mutat 2008;29:258-66.
12. Bansal D, Miyake K, Vogel SS, et al. Defective membrane repair in dysferlindeficient muscular dystrophy. Nature 2003;423:168-72.
13. De Luna N, Gallardo E, Soriano M, et al. Absence of dysferlin alters myogenin expression and delays human muscle differentiation "In vitro". J Biol Chem 2006;281:17092-8.
14. Klinge L, Laval S, Keers S, et al. From T-tubule to sarcolemma: Damage-induced dysferlin translocation in early myogenesis. FASEB J 2007;21:1768-76. (Pubitemid 46855623)
15. Klinge L, Harris J, Sewry CA, et al. Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle. Muscle Nerve 2010;41:166-73.
16. Chiu Y, Mark H, Klinge L, et al. Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy. Hum Mol Genet 2009;18:1976-89.
17. Kesari A, Fukuda M, Knoblach S, et al. Dysferlin deficiency shows compensatory induction of rab27a/slp2a that may contribute to inflammatory onset. Am J Pathol 2008;173:1476-87.
18. Selcen D, Stilling G, Engel AG. The earliest pathologic alterations in dysferlinopathy. Neurology 2001;56:1472-81.
19. Nagaraju K, Rawat R, Veszelovszky E, et al. Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2b. Am J Pathol 2008;172:774-85. (Pubitemid 351354549)
20. Mahjneh I, Marconi G, Bushby K, et al. Dysferlinopathy (LGMD2b): a 23-year follow-up study of 10 patients homozygous for the same frameshifting dysferlin mutations. Neuromuscul Disord 2001;11:20-6. (Pubitemid 32106878)
21. Personius KE, Pandya S, King WM, et al. Facioscapulohumeral dystrophy natural history study: Standardization of testing procedures and reliability of measurements. The FSH DY group. Phys Ther 1994;74:253-63. (Pubitemid 24067063)
22. Anderson LV, Davison K. Multiplex western blotting system for the analysis of muscular dystrophy proteins. Am J Pathol 1999;154:1017-22. (Pubitemid 29169736)
23. Johnson MA. Immunocytochemical analysis. In: Bushby K, Anderson LVB, eds. Muscular dystrophy: methods and protocols. Totowa: Humana Press, 2001:339-67.
24. Anderson LV, Harrison RM, Pogue R, et al. Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2b and miyoshi myopathy (primary dysferlinopathies). Neuromuscul Disord 2000;10:553-9.
25. Walter MC, Braun C, Vorgerd M, et al. Variable reduction of caveolin-3 in patients with lgmd2b/mm. J Neurol 2003;250:1431-8. (Pubitemid 38121839)
26. Klinge L, Dean AF, Kress W, et al. Late onset in dysferlinopathy widens the clinical spectrum. Neuromuscul Disord 2008;18:288-90.
27. Paradas C, Gonzalez-Quereda L, De Luna N, et al. A new phenotype of dysferlinopathy with congenital onset. Neuromuscul Disord 2009;19:21-5.
28. Weiler T, Bashir R, Anderson Lv, et al. Identical mutation in patients with limb girdle muscular dystrophy type 2b or miyoshi myopathy suggests a role for modifier gene(s). Hum Mol Genet 1999;8:871-7.
29. Illarioshkin SN, Ivanova-Smolenskaya IA, Greenberg CR, et al. Identical dysferlin mutation in limb-girdle muscular dystrophy type 2b and distal myopathy. Neurology 2000;55:1931-3.
30. Vilchez JJ, Gallano P, Gallardo E, et al. Identification of a novel founder mutation in the DYSF gene causing clinical variability in the spanish population. Arch Neurol 2005;62:1256-9.
31. Illa I, De Luna N, Dominguez-Perles R, et al. Symptomatic dysferlin gene mutation carriers: characterization of two cases. Neurology 2007;68:1284-9. (Pubitemid 46625974)